Approval covers all current IV isatuximab indications and introduces the first oncology product labeled for both OBI and manual SC administration. IRAKLIA (NCT05405166) established noninferiority of ...
Awareness of all the ways prompt injection can be effected will help security teams spot a new generation of attacks.
In 2025 and 2026, several independent sources have highlighted the same trend: Prompt injection remains one of the most impactful and widely demonstrated attack vectors against LLM systems. The OWASP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results